{"podcast":{"title":"The AI in Business Podcast","slug":"the-ai-in-business-podcast-168928","podcast_index_feed_id":168928,"rss_url":"https://techemergence.libsyn.com/rss","website_url":"http://emerj.com","image_url":"https://static.libsyn.com/p/assets/9/c/2/2/9c226d0d338dd5bed959afa2a1bf1c87/1.png","author":"Daniel Faggella","episode_count":1163,"summary":"The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI. Each week, Emerj research staff and journalists interview top AI executives from Fortune 2000 firms and unicorn startups - uncovering trends, use-cases, and best practices for practical AI adoption. Visit our advertising page to learn more about reaching our executive audience of Fortune 2000 AI adopters: https://emerj.com/advertise","last_synced_at":"2026-07-04T00:20:08.438260+00:00","page_url":"https://stenobird.com/podcast/the-ai-in-business-podcast-168928"},"episode":{"title":"Scaling Scientific R&D with AI Supercomputing Infrastructure — with Thomas Fuchs of Eli Lilly","slug":"scaling-scientific-r-d-with-ai-supercomputing-infrastructure-with-thomas-fuchs-of-eli-lilly","published_at":"2026-05-19T06:00:00+00:00","page_url":"https://stenobird.com/podcast/the-ai-in-business-podcast-168928/scaling-scientific-r-d-with-ai-supercomputing-infrastructure-with-thomas-fuchs-of-eli-lilly","show_page_url":"https://stenobird.com/podcast/the-ai-in-business-podcast-168928","url":"https://podcast.emerj.com/scaling-scientific-rd-with-ai-supercomputing-infrastructure-with-thomas-fuchs-of-eli-lilly","audio_url":"https://traffic.libsyn.com/secure/techemergence/AIB_Thomas_Fuchs.mp3?dest-id=151434","summary":"A growing share of pharmaceutical innovation is now constrained not by scientific imagination, but by the infrastructure required to support AI at scale. In this episode of the AI in Business podcast, Thomas Fuchs, Chief AI Officer at Eli Lilly & Company, joins Matthew DeMello to explore how Lilly's new AI supercomputing platform is reshaping scientific discovery and enterprise operations. The conversation examines how large-scale computing enables more advanced models, secure and usable data environments, and faster scientific iteration across the organization. Learn how brands work with Emerj and other Emerj Media options at go.emerj.com/partner","meta_description":"A growing share of pharmaceutical innovation is now constrained not by scientific imagination, but by the infrastructure required to support AI at scale.…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1516,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-ai-in-business-podcast-168928/episodes/scaling-scientific-r-d-with-ai-supercomputing-infrastructure-with-thomas-fuchs-of-eli-lilly/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-ai-in-business-podcast-168928/scaling-scientific-r-d-with-ai-supercomputing-infrastructure-with-thomas-fuchs-of-eli-lilly.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}